Status:
COMPLETED
The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to explain the effect of food order/nutrient sequencing on glycemic excursions over a 2 week period, utilizing a device known as a continuous glucose monitor (CGM), for pe...
Eligibility Criteria
Inclusion
- Metformin-treated type 2 diabetes of less than 10 years duration
- Must be on a stable dose of metformin for at least 1 month
- HbA1c ≤8.5 percent
Exclusion
- Relevant food allergies
- Oral steroid therapy within 90 days of enrollment
- Anti-diabetic medications other than metformin
- History of bariatric surgery
- Pregnant women
- Any participant deemed unsuitable in the investigator's opinion
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04738799
Start Date
April 29 2021
End Date
July 3 2023
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021